Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.20.1
Warrants
3 Months Ended
Mar. 31, 2020
Warrants and Rights Note Disclosure [Abstract]  
Warrants

NOTE 7 - WARRANTS

 

Warrants to purchase an aggregate of 2,363,304 shares of the Company’s common stock were outstanding at March 31, 2020. These warrants are all vested and exercisable, have exercise prices ranging from $0.15 to $93.00 per share, with a weighted average exercise price of $2.04, and expire at various dates through November 2023. For the three-month period ending March 31, 2020, the Company received proceeds of approximately $614,000 from warrant exercises resulting in the issuance of 6.0 million common shares of Company common stock.